Search

everythinglearnresearchcommunity

for

Search:↓

Long-term Finasteride treatment reduces depression better than short-term treatment in rats.

Finasteride's negative effects on brain tissue in male rats may be reversible after stopping the drug.

Dermatologists recommend oral dutasteride for male hair loss, low-dose oral minoxidil for female hair loss, and a multidisciplinary approach for young patients, with caution during pregnancy.

Dutasteride is more effective than finasteride for hair loss treatment.

Dutasteride effectively treats hair loss and prostate issues.

Finasteride may help treat childhood brain tumors by activating certain genes.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

Men with male pattern baldness may not have different hormone levels, but their hair follicles are likely more sensitive to hormones.

Finasteride reduces bleeding during prostate surgery.

Finasteride may reduce prostate tumor cell invasion and spread.

Finasteride causes reproductive malformations in male rats.

Finasteride causes reproductive changes in male rats.

Dutasteride is approved to help manage prostate enlargement.

Serenoa repens is not proven effective for hair loss and may delay prostate cancer detection.

Short-term finasteride use likely doesn't harm male fertility.

Taking 1mg of finasteride daily for hair loss can lower PSA levels by 40-50%, so to keep PSA effective as a cancer screening tool, the PSA value should be doubled during treatment.

Stress increases neurosteroids that help prevent seizures.

Different causes of hair loss require specific treatments, and most men and women will experience some form of hair thinning as they age.

Antiandrogens and finasteride may help treat excess hair and hair loss in women.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Oral finasteride may cause more sexual side effects than expected, possibly due to negative publicity and reporting bias.

Finasteride and dutasteride can improve hair loss in women, but more research is needed.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

New pyrazole derivatives may help treat hair loss, but more testing is needed.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatment strategies.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Personalized treatments for hair loss are becoming more effective by using genetic information.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.